Healthcare -
Biotechnology - NASDAQ - US
$ 24.05
-4.37 %
$ 2.99 B
Market Cap
-15.03
P/E
APLS - CASH & EQUIVALENTS
Cash & Equivalents APLS - Apellis Pharmaceuticals, Inc.
351 M
LAST VALUE
-25.94%
2 YEAR CAGR
14.78%
5 YEAR CAGR
53.75%
10 YEAR CAGR